Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ismael Fernández-Miranda"'
Autor:
Alicia Sánchez-Sanz, María Posada-Ayala, Julia Sabín-Muñoz, Ismael Fernández-Miranda, Yolanda Aladro-Benito, Roberto Álvarez-Lafuente, Ana Royuela, Ruth García-Hernández, Ofir Rodríguez-De la Fuente, Julián Romero, Antonio García-Merino, Antonio José Sánchez-López
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract The endocannabinoid system (ECS), a signalling network with immunomodulatory properties, is a potential therapeutic target in multiple sclerosis (MS). Dimethyl fumarate (DMF) is an approved drug for MS whose mechanism of action has not been
Externí odkaz:
https://doaj.org/article/dc14a0194f1344d1a8ef18b5b2fed8c6
Autor:
Marta Rodríguez, Ruth Alonso‐Alonso, Ismael Fernández‐Miranda, Rufino Mondéjar, Laura Cereceda, Álvaro Tráscasa, Anabel Antonio‐Da Conceiçao, Jennifer Borregón, Lucía Gato, Laura Tomás‐Roca, Carmen Bárcena, Begoña Iglesias, Fina Climent, Eva González‐Barca, Francisca Inmaculada Camacho, Émpar Mayordomo, Gabriel Olmedilla, Pilar Gómez‐Prieto, Yolanda Castro, Juana Serrano‐López, Joaquín Sánchez‐García, Santiago Montes‐Moreno, Mónica García‐Cosío, Paloma Martín‐Acosta, Juan F. García, María Planelles, Cristina Quero, Mariano Provencio, Ignacio Mahíllo‐Fernández, Socorro M. Rodríguez‐Pinilla, Enrico Derenzini, Stefano Pileri, Margarita Sánchez‐Beato, Raúl Córdoba, Miguel A. Piris
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 722-733 (2022)
Abstract Diffuse large B‐cell lymphoma (DLBCL), the most frequent non‐Hodgkin's lymphoma subtype, is characterized by strong biological, morphological, and clinical heterogeneity, but patients are treated with immunochemotherapy in a relatively h
Externí odkaz:
https://doaj.org/article/50ed2e5cc7ed44c6a502a8b55e0a336c
Autor:
Amelia Insa, Mariano Provencio, Bartomeu Massutí, Margarita Majem, Delvys Rodriguez-Abreu, Manuel Cobo, Manuel Dómine, Ernest Nadal, Belén Sierra-Rodero, Alberto Cruz-Bermúdez, Alex Martinez-Marti, Javier De Castro Carpeño, Guillermo López Vivanco, Edel Del Barco, Nuria Viñolas, Isidoro Barneto Aranda, Marta Casarrubios, Atocha Romero, Reyes Bernabe, María del Rosario García-Campelo, Martín Lázaro-Quintela, Cristina Martinez-Toledo, Ismael Fernández-Miranda, Roberto Serna-Blanco, Virginia Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background Neoadjuvant chemoimmunotherapy for non-small cell lung cancer (NSCLC) has improved pathological responses and survival rates compared with chemotherapy alone, leading to Food and Drug Administration (FDA) approval of nivolumab plus chemoth
Externí odkaz:
https://doaj.org/article/536d1ef3434247f3bec7c014036712de
Autor:
Elena Delgado, Aurora Fernández-García, Marcos Pérez-Losada, María Moreno-Lorenzo, Ismael Fernández-Miranda, Sonia Benito, Vanessa Montero, Horacio Gil, Silvia Hernáez, Josefa Muñoz, Miren Z. Zubero-Sulibarria, Elena García-Bodas, Mónica Sánchez, Jorge del Romero, Carmen Rodríguez, Luis Elorduy, Elena Bereciartua, Esther Culebras, Icíar Rodríguez-Avial, María Luisa Giménez-Alarcón, Carmen Martín-Salas, Carmen Gómez-González, José J. García-Irure, Gema Cenzual, Ana Martínez-Sapiña, María Maiques-Camarero, Lucía Pérez-Álvarez, Michael M. Thomson
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Circulating recombinant forms (CRFs) contribute substantially to the HIV-1 pandemic. Among 105 CRFs described in the literature, 16 are BF intersubtype recombinants, most of South American origin, of which CRF12_BF is the most widely spread.
Externí odkaz:
https://doaj.org/article/bc7dcde9066b465f828a631ef67448d8
Autor:
Lucía Pedrosa, Ismael Fernández-Miranda, David Pérez-Callejo, Cristina Quero, Marta Rodríguez, Paloma Martín-Acosta, Sagrario Gómez, Julia González-Rincón, Adrián Santos, Carlos Tarin, Juan F. García, Francisco R. García-Arroyo, Antonio Rueda, Francisca I. Camacho, Mónica García-Cosío, Ana Heredero, Marta Llanos, Manuela Mollejo, Miguel Piris-Villaespesa, José Gómez-Codina, Natalia Yanguas-Casás, Antonio Sánchez, Miguel A. Piris, Mariano Provencio, Margarita Sánchez-Beato
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease whose prognosis is associated with clinical features, cell-of-origin and genetic aberrations. Recent integrative, multi-omic analyses had led to identifying overlapping genetic
Externí odkaz:
https://doaj.org/article/2d5795c274074d96834193cbf41542ef
Autor:
Elena Delgado, Aurora Fernández-García, Marcos Pérez-Losada, María Moreno-Lorenzo, Ismael Fernández-Miranda, Sonia Benito, Vanessa Montero, Horacio Gil, Silvia Hernáez, Josefa Muñoz, Miren Z. Zubero-Sulibarria, Elena García-Bodas, Mónica Sánchez, Jorge del Romero, Carmen Rodríguez, Luis Elorduy, Elena Bereciartua, Esther Culebras, Icíar Rodríguez-Avial, María Luisa Giménez-Alarcón, Carmen Martín-Salas, Carmen Gómez-González, José J. García-Irure, Gema Cenzual, Ana Martínez-Sapiña, María Maiques-Camarero, Lucía Pérez-Álvarez, Michael M. Thomson
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/1cd820beb46f4b0a8202c4fa7204a20c
Publikováno v:
Cancers, Vol 13, Iss 12, p 2893 (2021)
Lymphoma research is a paradigm of the integration of basic and clinical research within the fields of diagnosis and therapy. Clinical, phenotypic, and genetic data are currently used to predict which patients could benefit from standard treatment. H
Externí odkaz:
https://doaj.org/article/bd4e55e85aed456eb8ad7de3a7113eda
Autor:
Margarita Sánchez-Beato, Mariano Provencio, Antonio Rueda-Domínguez, Virginia Calvo, Natalia Yanguas-Casás, Marta Navarro, Silvia Sequero, Miguel Marín, Natividad Martínez, Laura Gálvez, Ana K. Ballesteros, Beatriz Horcajo, Josep Gumá, Francisco R. García-Arroyo, Paloma Martín-Acosta, Sagrario Gómez, Fernando F. Franco, Marta Llanos, Lucía Pedrosa, Ismael Fernández-Miranda
Purpose:Follicular lymphoma (FL) is the most frequent indolent non-Hodgkin lymphoma. Around 20% of patients suffer early disease progression within 24 months (POD24) of diagnosis. This study examined the significance of circulating tumor DNA (ctDNA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c2e834f5dd00f81f35e923a68d79bd
https://doi.org/10.1158/1078-0432.c.6532949.v1
https://doi.org/10.1158/1078-0432.c.6532949.v1
Autor:
Margarita Sánchez-Beato, Mariano Provencio, Antonio Rueda-Domínguez, Virginia Calvo, Natalia Yanguas-Casás, Marta Navarro, Silvia Sequero, Miguel Marín, Natividad Martínez, Laura Gálvez, Ana K. Ballesteros, Beatriz Horcajo, Josep Gumá, Francisco R. García-Arroyo, Paloma Martín-Acosta, Sagrario Gómez, Fernando F. Franco, Marta Llanos, Lucía Pedrosa, Ismael Fernández-Miranda
Supplementary Data 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9bfb083e0b5ac640079fd14a6b4fd0
https://doi.org/10.1158/1078-0432.22489421
https://doi.org/10.1158/1078-0432.22489421
Autor:
Margarita Sánchez-Beato, Mariano Provencio, Antonio Rueda-Domínguez, Virginia Calvo, Natalia Yanguas-Casás, Marta Navarro, Silvia Sequero, Miguel Marín, Natividad Martínez, Laura Gálvez, Ana K. Ballesteros, Beatriz Horcajo, Josep Gumá, Francisco R. García-Arroyo, Paloma Martín-Acosta, Sagrario Gómez, Fernando F. Franco, Marta Llanos, Lucía Pedrosa, Ismael Fernández-Miranda
Supplementary Data 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e26bfa080bbec8a30c56f39870346bd
https://doi.org/10.1158/1078-0432.22489424
https://doi.org/10.1158/1078-0432.22489424